Vaccine development: perspectives from life-history traits

被引:0
作者
Balasubramanian, Deevitha [1 ]
Mukherjee, Raju [1 ]
机构
[1] Indian Inst Sci Educ & Res, Dept Biol, Tirupati 517507, India
来源
CURRENT SCIENCE | 2023年 / 124卷 / 09期
关键词
Immune response; life-history traits; pathogenesis cycle; route of administration; vaccine development; IMMUNE-RESPONSES; INTRANASAL; MEMORY; VIRUS; ROUTE; IMMUNIZATION; PERSISTENCE; SARS-COV-2; CANDIDATE; MUCOSAL;
D O I
10.18520/cs/v124/i9/1039-1052
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Major breakthroughs in vaccinology arise from our understanding of the fundamentals of immunology and infection biology of the disease. The pathogenicity cycle of a microorganism, from its introduction into the host until the resultant effects of infection, is closely linked to the host's immune response towards the pathogen. Additionally, questions in vaccinology, such as what determines the most efficacious route for vaccine delivery and whether mimicking infection from a different route of entry will generate a better immune response, remain open and may not be fully addressed during vaccine development. This article highlights the importance of the life-history traits of the pathogens and enumerates their relevance in designing vaccines. We revisit the path from life-history traits to vaccine development considering the pathogenicity cycle, which may prove critical in designing effective future vaccines and predicting vaccine behaviour in humans.
引用
收藏
页码:1039 / 1052
页数:14
相关论文
共 105 条
  • [1] Design of a Multiepitope-Based Peptide Vaccine against the E Protein of Human COVID-19: An Immunoinformatics Approach
    Abdelmageed, Miyssa I.
    Abdelmoneim, Abdelrahman H.
    Mustafa, Mujahed I.
    Elfadol, Nafisa M.
    Murshed, Naseem S.
    Shantier, Shaza W.
    Makhawi, Abdelrafie M.
    [J]. BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [2] Abeysundara A., 2017, INT J FOOD SCI NUTR, V2, P19
  • [3] Amanna I.J., 2018, Current Topics in Microbiology and Immunology, V428, P1
  • [4] B cell analyses after SARS-CoV-2 mRNA third vaccination reveals a hybrid immunity like antibody response
    Andreano, Emanuele
    Paciello, Ida
    Pierleoni, Giulio
    Piccini, Giulia
    Abbiento, Valentina
    Antonelli, Giada
    Pileri, Piero
    Manganaro, Noemi
    Pantano, Elisa
    Maccari, Giuseppe
    Marchese, Silvia
    Donnici, Lorena
    Benincasa, Linda
    Giglioli, Ginevra
    Leonardi, Margherita
    De Santi, Concetta
    Fabbiani, Massimiliano
    Rancan, Ilaria
    Tumbarello, Mario
    Montagnani, Francesca
    Sala, Claudia
    Medini, Duccio
    De Francesco, Raffaele
    Montomoli, Emanuele
    Rappuoli, Rino
    [J]. NATURE COMMUNICATIONS, 2023, 14 (01)
  • [5] The lightning-fast quest for COVID vaccines - and what it means for other diseases
    Ball, Philip
    [J]. NATURE, 2021, 589 (7840) : 16 - 18
  • [6] Localized Mucosal Response to Intranasal Live Attenuated Influenza Vaccine in Adults
    Barria, Maria Ines
    Garrido, Jose Luis
    Stein, Cheryl
    Scher, Erica
    Ge, Yongchao
    Engel, Stephanie M.
    Kraus, Thomas A.
    Banach, David
    Moran, Thomas M.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2013, 207 (01) : 115 - 124
  • [7] Begon M., 2005, Ecology: from individuals to ecosystems, V4, DOI DOI 10.1016/0169-5347(91)90151-M
  • [8] Infection routes matter in population-specific responses of the red flour beetle to the entomopathogen Bacillus thuringiensis
    Behrens, Sarah
    Peuss, Robert
    Milutinovic, Barbara
    Eggert, Hendrik
    Esser, Daniela
    Rosenstiel, Philip
    Schulenburg, Hinrich
    Bornberg-Bauer, Erich
    Kurtz, Joachim
    [J]. BMC GENOMICS, 2014, 15
  • [9] Harnessing local and systemic immunity for vaccines against tuberculosis
    Beverley, P. C. L.
    Sridhar, S.
    Lalvani, A.
    Tchilian, E. Z.
    [J]. MUCOSAL IMMUNOLOGY, 2014, 7 (01) : 20 - 26
  • [10] Birkhoff M, 2009, INDIAN J PHARM SCI, V71, P729